Your browser doesn't support javascript.
loading
Recent Progress in the Development of Opaganib for the Treatment of Covid-19.
Smith, Charles D; Maines, Lynn W; Keller, Staci N; Katz Ben-Yair, Vered; Fathi, Reza; Plasse, Terry F; Levitt, Mark L.
Affiliation
  • Smith CD; Apogee Biotechnology Corporation, Hummelstown, PA, USA.
  • Maines LW; Apogee Biotechnology Corporation, Hummelstown, PA, USA.
  • Keller SN; Apogee Biotechnology Corporation, Hummelstown, PA, USA.
  • Katz Ben-Yair V; RedHill Biopharma LTD, Tel Aviv, Israel.
  • Fathi R; RedHill Biopharma LTD, Tel Aviv, Israel.
  • Plasse TF; RedHill Biopharma LTD, Tel Aviv, Israel.
  • Levitt ML; RedHill Biopharma LTD, Tel Aviv, Israel.
Drug Des Devel Ther ; 16: 2199-2211, 2022.
Article in En | MEDLINE | ID: mdl-35855741
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Guideline Limits: Humans Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Guideline Limits: Humans Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Country of publication: